Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB06817_nanopub.RAp4PhkP-layU1PfydZ7VXG_6OdQWZkPIW7Yl5wv45hsQ#assertion>. }
Showing items 1 to 16 of
16
with 100 items per page.
- drugbank:DB06817 type drugbank_vocabulary:Drug assertion.
- drugbank:DB06817 label "Raltegravir [drugbank:DB06817]" assertion.
- drugbank:DB06817 seeAlso isentress.html assertion.
- drugbank:DB06817 seeAlso DB06817 assertion.
- drugbank:DB06817 description "Raltegravir is an antiretroviral drug produced by Merck & Co., used to treat HIV infection. It received approval by the U.S. Food and Drug Administration (FDA) on 12 October 2007, the first of a new class of HIV drugs, the integrase inhibitors, to receive such approval. [Wikipedia]" assertion.
- drugbank:DB06817 identifier "drugbank:DB06817" assertion.
- drugbank:DB06817 title "Raltegravir" assertion.
- drugbank:DB06817 drugbank_vocabulary:x-cas cas:518048-05-0 assertion.
- drugbank:DB06817 drugbank_vocabulary:drugbank-id "DB05355" assertion.
- drugbank:DB06817 drugbank_vocabulary:drugbank-id "DB06817" assertion.
- drugbank:DB06817 bio2rdf_vocabulary:x-identifiers.org DB06817 assertion.
- drugbank:DB06817 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB06817" assertion.
- drugbank:DB06817 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB06817 bio2rdf_vocabulary:identifier "DB06817" assertion.
- drugbank:DB06817 drugbank_vocabulary:x-wikipedia wikipedia:Raltegravir assertion.
- drugbank:DB06817 drugbank_vocabulary:x-kegg kegg:D06676 assertion.